Replies to post #809922 on NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Correct. Its simple - if a company hasn’t even applied to FDA, 5+ years since data lock, that just indicates the trial is not approvable. Its because US is by far the biggest (over 50% of the world’s immunotherapy market and over 10-20X of the tiny) and the most lucrative market. No serious and successful company would take this long to apply to the US.

3rd generation of bag holders will be trapped and wiped off as they hit 2.7B outstanding shares in 2027.

LP’s financiers and shorts will make a ton of easy money again because they can count on the false expectations and timing inaccuracies that LP and her minions will set! ;)

[HyGro]

No argument here. Totally redesigning a clinical trial 12 YEARS after it started is pretty incredible. Redesigned the protocol, changed the primary endpoint (when they knew they would fail the original), change the comparator to a cherry picked set of trials for an ECA (multiple trials had different screeners).

Incredible amount of bias introduced. And the FDA wouldn't buy it -- so NWBO, out of desperation had to find another regulator to pitch their "updated" trial. FDA had followed the trial for over 12 years and saw all of the NWBO manipulations.